Pediatric Corneal Crosslinking: Is It Necessary to Document Progression? No | ASCRS
Menu
Home Clinical Education Cornea Pediatric Corneal Crosslinking: Is It Necessary to Document Progression? No
Presentation
Pediatric Corneal Crosslinking: Is It Necessary to Document Progression? No
May 2019
Meeting: 2019 Annual Meeting
Session: SYM-104: Keratoconus: Consensus and Controversy
Presenter: Maria A. Henriquez, MD, PhD
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

This presentation ilustrate the agressivity of keratoconus in children. Remarks are provided on the ethical and medical reasons to perform CXL in children and explain why, in some cases we should not wait for progression.
Filed Under
Cornea crosslinking pediatric keratoconus
View More Presentations from SYM-104

This presentation is from the session "SYM-104: Keratoconus: Consensus and Controversy" from the 2019 ASCRS Annual Meeting held on May 4-7, 2019 in San Diego, California.

View More From This Session
Browse All 2019 Annual Meeting Presentations On Demand

Related Content

Poster
IC-209 Two Decades of Corneal Cross-Linking: Current Indications, Applications, Outcomes, and Complications-Management; The US, FDA-Approved Technique and Evolving Technology and Techniques
July 2021
Presentation
Corneal Crosslinking Biomechanics Evaluated By a Novel and Easily Implemented Differential Tonometry Method
Sean J. McCafferty, MD, FACS, Nathan Radcliffe MD 05:08 minutes
May 2020
Poster
Cross Linked Donor Corneas Resist Infections and Melts in Boston Type 1 Keratoprosthesis - a Case Series
Lional Raj Daniel Raj Ponniah, MD
May 2019
Presentation
Crosslinking: Current FDA Approved Technique
W. Barry Lee, MD 15:05 minutes
July 2021
American
About ASCRS
Clinical Education
Meetings
Tools
ASCRS foundation
Donate
Contact Us

© 2021 ASCRS. All Rights Reserved.

Advertise Legal Notice

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.